IL155604A0 - Tripeptidyl peptidase inhibitors - Google Patents
Tripeptidyl peptidase inhibitorsInfo
- Publication number
- IL155604A0 IL155604A0 IL15560401A IL15560401A IL155604A0 IL 155604 A0 IL155604 A0 IL 155604A0 IL 15560401 A IL15560401 A IL 15560401A IL 15560401 A IL15560401 A IL 15560401A IL 155604 A0 IL155604 A0 IL 155604A0
- Authority
- IL
- Israel
- Prior art keywords
- tripeptidyl peptidase
- peptidase inhibitors
- inhibitors
- cholecystokinis
- ccks
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24422300P | 2000-10-30 | 2000-10-30 | |
| PCT/US2001/012388 WO2001080419A2 (en) | 2000-04-18 | 2001-04-17 | System and method for frequency translation using an image reject mixer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155604A0 true IL155604A0 (en) | 2003-11-23 |
Family
ID=22921880
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15560401A IL155604A0 (en) | 2000-10-30 | 2001-10-24 | Tripeptidyl peptidase inhibitors |
| IL155604A IL155604A (en) | 2000-10-30 | 2003-04-28 | Tripteptidyl peptidase inhibitors, pharmaceutical preparations containing them and processes for their preparation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL155604A IL155604A (en) | 2000-10-30 | 2003-04-28 | Tripteptidyl peptidase inhibitors, pharmaceutical preparations containing them and processes for their preparation |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US7125891B2 (xx) |
| EP (1) | EP1392291B1 (xx) |
| JP (1) | JP2004512365A (xx) |
| KR (1) | KR100820598B1 (xx) |
| CN (2) | CN101307046B (xx) |
| AT (1) | ATE363276T1 (xx) |
| AU (2) | AU2002224797B2 (xx) |
| BG (1) | BG107729A (xx) |
| CA (1) | CA2422617C (xx) |
| CZ (1) | CZ20031422A3 (xx) |
| DE (1) | DE60128731T2 (xx) |
| DK (1) | DK1392291T3 (xx) |
| EA (1) | EA006443B1 (xx) |
| EE (1) | EE200300168A (xx) |
| ES (1) | ES2287185T3 (xx) |
| HU (1) | HU230376B1 (xx) |
| IL (2) | IL155604A0 (xx) |
| MX (1) | MXPA03003868A (xx) |
| NO (1) | NO324503B1 (xx) |
| NZ (1) | NZ525928A (xx) |
| PL (1) | PL205536B1 (xx) |
| PT (1) | PT1392291E (xx) |
| SK (1) | SK6282003A3 (xx) |
| WO (1) | WO2002036116A2 (xx) |
| ZA (1) | ZA200303302B (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101307046B (zh) | 2000-10-30 | 2012-08-15 | 詹森药业有限公司 | 三肽酶抑制剂 |
| US7041681B2 (en) | 2002-04-29 | 2006-05-09 | Janssen Pharmaceutica N.V. | Compounds as opioid receptor modulators |
| AU2012268813B2 (en) * | 2002-04-29 | 2015-04-30 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives as opioid modulators |
| AU2003280985A1 (en) * | 2002-07-10 | 2004-02-02 | Bayer Healthcare Ag | Regulation of human tripeptidyl peptidase ii |
| EP1581525A2 (en) | 2002-08-09 | 2005-10-05 | AstraZeneca AB | Compounds having an activity at metabotropic glutamate receptors |
| JP2007503453A (ja) * | 2003-05-14 | 2007-02-22 | ノボ ノルディスク アクティーゼルスカブ | 肥満症を治療するための新規化合物 |
| SI1725537T1 (sl) | 2004-03-15 | 2011-11-30 | Janssen Pharmaceutica Nv | Nove spojine kot modulatorji opioidnih receptorjev |
| MX2007011409A (es) * | 2005-03-14 | 2008-02-22 | Johnson & Johnson | Procedimiento de preparacion de moduladores opioides. |
| JP4955009B2 (ja) * | 2005-11-11 | 2012-06-20 | エフ．ホフマン−ラ ロシュ アーゲー | 凝固因子Ｘａの阻害剤としての炭素環式縮合環アミン |
| US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
| EP2034998A1 (en) | 2006-05-11 | 2009-03-18 | Janssen Pharmaceutica, N.V. | 1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors |
| JP2009536954A (ja) | 2006-05-11 | 2009-10-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃｅｔｐ阻害剤としての３，４−ジヒドロ−２ｈ−ベンゾ［１，４］オキサジンおよびチアジン誘導体 |
| US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
| GB0709031D0 (en) * | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds |
| GB201202027D0 (en) | 2012-02-06 | 2012-03-21 | Sareum Ltd | Pharmaceutical compounds |
| DK3040336T3 (da) | 2012-03-02 | 2020-06-22 | Sareum Ltd | Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande |
| EP2708535A1 (en) | 2012-05-11 | 2014-03-19 | Les Laboratoires Servier | Agents for treating disorders involving modulation of ryanodine receptors |
| US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
| US9675587B2 (en) | 2013-03-14 | 2017-06-13 | Allergan Holdings Unlimited Company | Opioid receptor modulator dosage formulations |
| GB201617871D0 (en) | 2016-10-21 | 2016-12-07 | Sareum Limited | Pharmaceutical compounds |
| JP6717968B2 (ja) * | 2016-11-01 | 2020-07-08 | 日本農薬株式会社 | Ｎ‐アルキルスルホニルインドリン化合物及び該化合物を含有する農園芸用殺虫剤並びにその使用方法 |
| CN114555594A (zh) * | 2019-10-17 | 2022-05-27 | 奇华顿股份有限公司 | 作为trmp8调节剂的取代的氮杂环 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE584914A (xx) | 1958-11-24 | |||
| JPS50439B1 (xx) | 1970-04-27 | 1975-01-09 | ||
| CH543479A (de) | 1970-05-06 | 1973-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von Phenyläthylaminderivaten |
| GB2146026A (en) | 1983-09-07 | 1985-04-11 | Tanabe Seiyaku Co | Peptides and process for preparing the same |
| JPS61227506A (ja) | 1985-04-01 | 1986-10-09 | Nippon Tokushu Noyaku Seizo Kk | カルバモイルイミダゾ−ル類、その中間体、それらの製法並びに除草剤又は農園芸用殺菌剤 |
| US5159081A (en) | 1991-03-29 | 1992-10-27 | Eli Lilly And Company | Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists |
| US5338135A (en) | 1991-04-11 | 1994-08-16 | Sumitomo Electric Industries, Ltd. | Drill and lock screw employed for fastening the same |
| FR2678938B1 (fr) | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
| JPH05339240A (ja) | 1992-06-04 | 1993-12-21 | Yamanouchi Pharmaceut Co Ltd | テトラヒドロイソキノリンアミド誘導体 |
| SE9402880D0 (sv) | 1994-08-30 | 1994-08-30 | Astra Ab | New peptide derivatives |
| FR2733995B1 (fr) | 1995-05-09 | 1997-07-25 | Inst Nat Sante Rech Med | Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments |
| FR2735776B1 (fr) | 1995-06-22 | 1997-07-18 | Synthelabo | Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique |
| JP2001505585A (ja) * | 1996-12-16 | 2001-04-24 | 藤沢薬品工業株式会社 | 新規アミド化合物およびそれらの一酸化窒素シンターゼ阻害剤としての用途 |
| US5965537A (en) * | 1997-03-10 | 1999-10-12 | Basf Aktiengesellschaft | Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus |
| US6335360B1 (en) | 1997-12-23 | 2002-01-01 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Tripeptidyl peptidase inhibitors |
| AU3768799A (en) * | 1998-04-28 | 1999-11-16 | Trega Biosciences, Inc. | Isoquinoline compound melanocortin receptor ligands and methods of using same |
| CA2333960A1 (en) * | 1998-06-03 | 1999-12-09 | Gpi Nil Holdings, Inc. | Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
| US6916905B2 (en) | 2000-03-24 | 2005-07-12 | The United States Of America As Represented By The Department Of Health And Human Services | Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use |
| CN101307046B (zh) * | 2000-10-30 | 2012-08-15 | 詹森药业有限公司 | 三肽酶抑制剂 |
| FR2816207B1 (fr) | 2000-11-08 | 2003-01-03 | Oreal | Composition de teinture d'oxydation pour fibres keratiniques comprenant un polyurethane associatif cationique |
| US6755387B2 (en) | 2001-02-08 | 2004-06-29 | Symons Corporation | Transition strip for disparate concrete forms |
-
2001
- 2001-10-24 CN CN2008101078402A patent/CN101307046B/zh not_active Expired - Lifetime
- 2001-10-24 CZ CZ20031422A patent/CZ20031422A3/cs unknown
- 2001-10-24 DE DE60128731T patent/DE60128731T2/de not_active Expired - Lifetime
- 2001-10-24 KR KR1020037004180A patent/KR100820598B1/ko active IP Right Grant
- 2001-10-24 JP JP2002538928A patent/JP2004512365A/ja active Pending
- 2001-10-24 PL PL361064A patent/PL205536B1/pl unknown
- 2001-10-24 CA CA2422617A patent/CA2422617C/en not_active Expired - Lifetime
- 2001-10-24 US US10/415,623 patent/US7125891B2/en not_active Expired - Lifetime
- 2001-10-24 EA EA200300523A patent/EA006443B1/ru not_active IP Right Cessation
- 2001-10-24 PT PT01992570T patent/PT1392291E/pt unknown
- 2001-10-24 AU AU2002224797A patent/AU2002224797B2/en not_active Expired
- 2001-10-24 WO PCT/EP2001/012388 patent/WO2002036116A2/en active IP Right Grant
- 2001-10-24 EE EEP200300168A patent/EE200300168A/xx unknown
- 2001-10-24 AU AU2479702A patent/AU2479702A/xx active Pending
- 2001-10-24 AT AT01992570T patent/ATE363276T1/de active
- 2001-10-24 ES ES01992570T patent/ES2287185T3/es not_active Expired - Lifetime
- 2001-10-24 DK DK01992570T patent/DK1392291T3/da active
- 2001-10-24 MX MXPA03003868A patent/MXPA03003868A/es active IP Right Grant
- 2001-10-24 CN CNB018181015A patent/CN100400040C/zh not_active Expired - Lifetime
- 2001-10-24 SK SK628-2003A patent/SK6282003A3/sk unknown
- 2001-10-24 HU HU0302770A patent/HU230376B1/hu unknown
- 2001-10-24 NZ NZ525928A patent/NZ525928A/en not_active IP Right Cessation
- 2001-10-24 IL IL15560401A patent/IL155604A0/xx unknown
- 2001-10-24 EP EP01992570A patent/EP1392291B1/en not_active Expired - Lifetime
-
2003
- 2003-04-16 BG BG107729A patent/BG107729A/bg active Pending
- 2003-04-28 IL IL155604A patent/IL155604A/en unknown
- 2003-04-29 NO NO20031930A patent/NO324503B1/no not_active IP Right Cessation
- 2003-04-29 ZA ZA200303302A patent/ZA200303302B/en unknown
-
2006
- 2006-08-07 US US11/499,937 patent/US20060276509A1/en not_active Abandoned
-
2007
- 2007-10-30 US US11/928,273 patent/US7947713B2/en not_active Expired - Fee Related
-
2011
- 2011-05-19 US US13/111,010 patent/US8247432B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2479702A (en) | Tripeptidyl peptidase inhibitors | |
| MX2009009540A (es) | Inhibidores de metaloproteasa que contienen una porcion heterociclica. | |
| YU65802A (sh) | Derivati azetidina, njihovo dobivanje i farmaceutske smeše koje ih sadrže | |
| BRPI0413973A (pt) | compostos | |
| MY136789A (en) | Metalloproteinase inhibitors | |
| HK1068626A1 (en) | Chemical compounds | |
| HK1096549A1 (en) | Imidazopyridine-derivatives as inducible no-synthase inhibitors | |
| ATE232873T1 (de) | Phosphonsaürederivate als ptp-1b-inhibitoren | |
| MY122829A (en) | Linezolid-crystal form ii | |
| BG104885A (en) | Novel heterocyclically substituted amides with cysteine protease-inhibiting effect | |
| BR0313969A (pt) | Inibidores de oxitocina | |
| SE0103710D0 (sv) | Compounds | |
| EA199800200A1 (ru) | Ингибиторы пролилэндопептидазы | |
| MY128164A (en) | Compounds | |
| ATE193526T1 (de) | Alkylierte styrole als prodrugs zu cox-2- inhibitoren | |
| DK0941975T3 (da) | Injiceringscement indeholdende korrosionshæmmere | |
| DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| NO20033921L (no) | Inhibitor av monoaminopptak | |
| MXPA03002493A (es) | Proceso eficiente para preparacion de un inhibidor del factor xa. | |
| GB2348423B (en) | Novel anhydrofructose antioxidant | |
| GB0205327D0 (en) | compounds | |
| WO2003104257A3 (en) | PROTEASE INHIBITORS | |
| WO2005034838A3 (en) | Protease inhibitors | |
| AU4865201A (en) | An intermediate and process for its synthesis | |
| BR9713684A (pt) | Inibidores de serina protease |